Epidemiological analysis of esophageal neoplasms in the southeast region of Brazil between 2011 and 2021
Article Sidebar
Main Article Content
Abstract
Objective: To describe the epidemiological analysis of the esophageal neoplasms on the Southeast region of Brazil between 2011 and 2021. Methods: This is an epidemiological study of ecological type based on data colected by SUS Informatical Department (DATASUS) through Cancer informational system (SISCAN- esophageal cancer). The population was composed by all notified cases of malignant esophageal neoplasms on the Southeast region of Brazil between 2011 and 2021, imputed on public domain generic tabulator (Tabnet) by International Statistical Classification of Diseases and Related Health Problems (ICD) C15. Variables as state, gender, age group and year were considered. The research was realized in November of 2023. Results: The mortality rate descreased since 2018, mainly among male and people above 50 years. The incidence, remained really simarly in the period under analysis with minimun reduction from 2016 onwards. It was observed high lethality rates in all analysed period, emphasizing the severity of this disease. Conclusion: More studies are necessary to fully compreend the factors that lead the high rates of incidence and lethality of esophageal cancer on the Southeast region of Brasil with the purpouse of diagnose and treat early.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. BRASIL. Ministério da Saúde. DATASUS. Tabnet. Brasília, DF: Ministério da Saúde, 2023. Disponível em: https://datasus.saude.gov.br/mortalidade-desde-1996-pela-cid-10v. Acessado em: 19 novembro de 2023.
3. BRASIL. Ministério da Saúde. Vigitel Brasil 2006-2011. Estimativas sobre a frequência e distribuição sociodemográfica de tabagismo e consumo abusivo de álcool nas capitais dos 26 estados brasileiros e no distrito federal entre 2006 e 2020. Brasília: Ministério da Saúde; 2022. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/vigitel/vigitel-brasil-2006-2020-e-tabagismo-e-consumo-abusivo-de-alcool.pdf. Acessado em: 24 novembro de 2023.
4. CRUZ AIBM, et al. Perfil dos Pacientes com Câncer de Esôfago Diagnosticados entre 2001 e 2010 no Brasil. Revista Brasileira de Cancerologia, 2018; 64(4): 471-477.
5. DERAKHSHAN, MH, et al. Worldwide inverse association between gastric cancer and esophageal adenocarcinoma suggesting a common environmental factor exerting opposing effects. The American journal of gastroenterology, 2016; 111(2), 228-239.
6. DONG J, et al. Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma. Gastroenterology, 2020; 159:2065–2076.
7. FARINATTI PTV. Teorias biológicas do envelhecimento: do genético ao estocástico. Revista Brasileira De Medicina Do Esporte, 2002; 8(4): 129–138.
8. GIMENO SGA, et al. Fatores de risco para o câncer de esôfago: estudo caso-controle em área metropolitana da região Sudeste do Brasil. Revista Saúde, 1995; 29(3): 159-165.
9. HAMEL C, et al. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Systematic Reviews, 2020; 9:20; 2.
10. HENRY MACA, et al. Esophageal cancer in patient with chagasic megaesophagus. Arq Gastroenterol. 2007; 44(2): 151-155.
11. INCA. Instituto Nacional de Câncer. Câncer de esôfago. 2022. Disponível em
12. INCA. Instituto Nacional de Câncer. Estimativa de 2023. Disponível em https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf. Acessado em: 15 de novembro de 2023.
13. IBGE. Instituto Brasileiro de Geografia e Estatística. Censo Brasileiro de 2022. Disponível em https://agenciadenoticias.ibge.gov.br/agencia-noticias/2012-agencia-de-noticias/noticias/37237-de-2010-a-2022-populacao-brasileira-cresce-6-5-e-chega-a-203-1-milhoes. Acessado em: 15 de novembro de 2023.
14. KUIAVA VA, et al. Epidemiological profile of esophageal cancer mortality in Rio Grande do Sul and its health regions. Revista Clinical & Biomedical Research. 2018; 38(3): 213-217.
15. LAGERGREN J, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New England journal of medicine, 1999; 340(11): 825-831.
16. MENEZES AM, et al. Risco de câncer de pulmão, laringe e esôfago atribuível ao fumo. Revista Saúde Pública. 2002; 36(2): 129-34.
17. QUEIROGA RC. Câncer de esôfago: epidemiologia, diagnóstico e tratamento. Revista Brasileira Cancerologia. 2006; 52(2): 173-178.
18. RIBEIRO LCB. Comparação entre as modalidades de tratamento do câncer de esôfago e da junção esofagogástrica no Instituto Nacional de Câncer - Brasil: um estudo observacional retrospectivo. Dissertação (Mestrado em Oncologia) – Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, 2019; 118p.
19. STROBE. 2023. Strengthening the reporting of observational studies in epidemiology. Disponível em: https://www.strobe-statement.org. Acesso em: 15 de novembro de 2023.
20. THULER FP, et al. Neoplasia avançada de esôfago: diagnóstico ainda muito tardio. Arq Gastroenterol. 2006; 43(3): 206–211.
21. XU Q, et al. The treatments and postoperative complications of esophageal cancer: a review. Journal of Cardiothoracic Surgery. 2020; 15:163; 2-4.